


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+4.61%
+0.08%
-8.89%
+0.11%
+0.02%
META
Meta Platforms
$667.55
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Outperform the market
META Price Performance
$633.61 (+5.36%)
$734.38 (-9.10%)
$776.37 (-14.02%)
$615.86 (+8.39%)
META has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Investors losing confidence

META overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Revenue increase YoY

Loss widens YoY

Earnings increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
META Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
META Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
GOOG
315.67
0.00%
PINS
26.13
+0.31%
WB
10.08
0.00%
TRIP
14.25
+1.79%
BIDU
123.36
-0.38%
What is META current stock price?
What are META stock strengths?
What is META Risk Level?
What is META market cap and volume?
What is META current Stock IQ?
Should I buy META stock right now?
Is META a Strong Buy right now?
What does a 'Strong Buy' rating mean for META?
What does a 'Strong Sell' rating mean for META?
What factors influence META's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+4.61%
+0.08%
-8.89%
+0.11%
+0.02%
META
Meta Platforms
Current Price
$667.55
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Outperform the market
Linked to META
GOOG
315.67
0.00%
PINS
26.13
+0.31%
WB
10.08
0.00%
TRIP
14.25
+1.79%
BIDU
123.36
-0.38%

META Price Performance
$633.61 (+5.36%)
$734.38 (-9.10%)
$776.37 (-14.02%)
$615.86 (+8.39%)
META Analysts Opinion
META Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Revenue increase YoY

Loss widens YoY

Earnings increase YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
META Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
META Street Sentiment is extremely bullish and have positive views on the near-term outlook
META has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Investors losing confidence

Average key support and resistance price levels
META Stock IQ
META Latest Analysis
Repare Therapeutics Stock Rises As Gilead Secures Cancer Asset For $30 Million. GILD) on Wednesday ) polymerase theta (Polθ) ATPase inhibitor RP-3467.RP-3467 is being evaluated in the POLAR Phase 1 trial to evaluate its safety pharmacokinetics pharmacodynamics and preliminary activity alone or in combination with olaparib in adults with locally advanced or metastatic epithelial ovarian cancer metastatic breast cancer metastatic castration-resistant prostate cancer or .“.We are pleased to a
Today
Amazon Meta SpaceX OpenAI And Trillion-Dollar IPOs Lead Futurum CEO Daniel Newmans Top 2026 Tech Predictions. on Tuesday. These predictions highlight long-term equity trends driven by AI infrastructure software platforms rising energy demand and changing patterns in capital allocation.
Today
How To Earn $500 A Month From Meta Stock. META) shares closed slightly higher during Tuesday'.s session.On Tuesday Baird analyst Colin Sebastian maintained Meta with an Outperform rating and lowered the price target from $820 to $815 according to Benzinga Pro.With the recent buzz around Meta some investors may be eyeing potential gains from the company'.s dividends too. As of now Meta offers an annual dividend yield of 0.32% which is a quarterly dividend amount of 52.5 cents per share ($
Today
META Factor-Based Stock Analysis - Peter Lynch. Below is Valideas guru fundamental report for META PLATFORMS INC (META). Of the 22 guru strategies we follow META rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price rela
Today
Meta Stock Price Target Trimmed By Analyst. Can Wounded Sentiment Recover In 2026?. Baird analysts called Meta stock a buy but said negative sentiment will carry into 2026 for the social media giant.The post Meta Stock Price Target Trimmed By Analyst. Can '.Wounded Sentiment'. Recover In 2026? appeared first on Investor'.s Business Daily.
Tue Dec 23, 2025
Meta Platforms To $815? Here Are 10 Top Analyst Forecasts For Tuesday. Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes including upgrades and downgrades please see our analyst ratings page.B of A Securities raised ARCB) price target from $72 to $84. B of A Securities analyst Ken Hoexter maintained a Neutral rating. ArcBest shares closed at $77.69 on Monday. See how other analysts view this stock.Morgan Stanley increased the pri
Tue Dec 23, 2025
Its time to buy the dip on Meta says Baird. Bairds price target for Meta implies an upside ahead of 23%.
Tue Dec 23, 2025
Wall Street ish on Netskope Inc. (NTSK) Heres Why. Netskope Inc. (NASDAQ:NTSK) is one of the Best Young Tech Stocks to Buy. Wall Street is ish on Netskope Inc. (NASDAQ:NTSK) as the company topped expectations during its first earnings release after the IPO. Recently on December 18 Meta Marshall from Morgan Stanley reiterated a Buy rating on the stock with a $27 price target. [….]
Tue Dec 23, 2025
RADX: Interim Readout Achieves 92% Concordance. By RAD101 Phase IIb Interim AnalysisRadiopharm Theranostics (NASDAQ:RADX) the primary endpoint for its RAD101 trial in an interim analysis on December 15th. Following the release management held a which featured the companys CEO Riccardo Canevari Chief Medical Officer Dr. Dimitris Voliotis and the principal investigator on the RAD101 trial Dr. Harshad Kulkarni.Topline from the release indicated that 92% (11/12) of evaluated patients treated with R
Mon Dec 22, 2025
How To Trade SPY QQQ AAPL MSFT NVDA GOOGL META TSLA Using Technical Analysis. Good Morning Traders! Today'.s session kicks off the holiday week with a lighter economic calendar which often leads to thinner liquidity and more exaggerated price moves. Traders will digest the November Chicago Fed National Activity Index which provides a broad snapshot of overall economic momentum. While not always a major market mover on its own it can still influence early sentiment in a low volume environment
Mon Dec 22, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
META Stock trends
META Stock performance
META Stock analysis
META investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.